TransMedics Group, Inc. (TMDX)

NASDAQ: TMDX · IEX Real-Time Price · USD
74.71
+0.59 (0.80%)
Mar 28, 2024, 1:59 PM EDT - Market open

Total Valuation

TMDX has a market cap or net worth of $2.44 billion. The enterprise value is $2.56 billion.

Market Cap 2.44B
Enterprise Value 2.56B

Important Dates

The next estimated earnings date is Monday, April 29, 2024, after market close.

Earnings Date Apr 29, 2024
Ex-Dividend Date n/a

Share Statistics

TMDX has 32.72 million shares outstanding. The number of shares has increased by 10.02% in one year.

Shares Outstanding 32.72M
Shares Change (YoY) +10.02%
Shares Change (QoQ) +0.10%
Owned by Insiders (%) 3.64%
Owned by Institutions (%) 111.85%
Float 31.56M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 10.09
Forward PS 6.52
PB Ratio 17.76
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 10.59
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.30, with a Debt / Equity ratio of 3.76.

Current Ratio 9.30
Quick Ratio 8.35
Debt / Equity 3.76
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1.47

Financial Efficiency

Return on equity (ROE) is -16.60% and return on invested capital (ROIC) is -4.40%.

Return on Equity (ROE) -16.60%
Return on Assets (ROA) -4.20%
Return on Capital (ROIC) -4.40%
Revenue Per Employee $413,738
Profits Per Employee -$42,856
Employee Count 584
Asset Turnover 0.41
Inventory Turnover 2.70

Taxes

Income Tax -1.64M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +2.95% in the last 52 weeks. The beta is 2.00, so TMDX's price volatility has been higher than the market average.

Beta (1Y) 2.00
52-Week Price Change +2.95%
50-Day Moving Average 83.19
200-Day Moving Average 72.15
Relative Strength Index (RSI) 46.74
Average Volume (30 Days) 626,431

Short Selling Information

The latest short interest is 5.41 million, so 16.53% of the outstanding shares have been sold short.

Short Interest 5.41M
Short Previous Month 4.98M
Short % of Shares Out 16.53%
Short % of Float 17.13%
Short Ratio (days to cover) 6.96

Income Statement

In the last 12 months, TMDX had revenue of $241.62 million and -$25.03 million in losses. Loss per share was -$0.77.

Revenue 241.62M
Gross Profit 154.09M
Operating Income -28.73M
Pretax Income -26.67M
Net Income -25.03M
EBITDA -6.66M
EBIT -15.88M
Loss Per Share -$0.77
Full Income Statement

Balance Sheet

The company has $395.31 million in cash and $515.95 million in debt, giving a net cash position of -$120.63 million or -$3.69 per share.

Cash & Cash Equivalents 395.31M
Total Debt 515.95M
Net Cash -120.63M
Net Cash Per Share -$3.69
Equity / Book Value 137.20M
Book Value Per Share 4.19
Working Capital 455.72M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$13.03 million and capital expenditures -$151.85 million, giving a free cash flow of -$164.88 million.

Operating Cash Flow -13.03M
Capital Expenditures -151.85M
Free Cash Flow -164.88M
FCF Per Share -$5.07
Full Cash Flow Statement

Margins

Gross margin is 63.77%, with operating and profit margins of -11.89% and -10.36%.

Gross Margin 63.77%
Operating Margin -11.89%
Pretax Margin -11.04%
Profit Margin -10.36%
EBITDA Margin -2.76%
EBIT Margin -6.57%
FCF Margin -68.24%

Dividends & Yields

TMDX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -10.02%
Shareholder Yield -10.02%
Earnings Yield -1.03%
FCF Yield -6.77%
Dividend Details

Analyst Forecast

The average price target for TMDX is $95.14, which is 26.48% higher than the current price. The consensus rating is "Buy".

Price Target $95.14
Price Target Difference 26.48%
Analyst Consensus Buy
Analyst Count 7
Revenue Growth Forecast (5Y) 36.68%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

TMDX has an Altman Z-Score of 2.61 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.61
Piotroski F-Score 1